BSE Code: 532523 | NSE Code: BIOCON | ISIN: INE376G01013 | Sector: Pharmaceuticals & Drugs
Updated:22 Feb, 2019, 15:58 PM IST
Updated:22 Feb, 2019, 16:01 PM IST
Steady business fundamentals. See improvement in the second wave of Biosimilar assets. Expect price earnings ratios to expand in the near term.